APA (7th ed.) Citation

S, K., R, v. S., K, S., D, B., L, P., D, B., . . . WJV, D. (2020). Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 30(6), 888. https://doi.org/10.1136/ijgc-2020-001231

Chicago Style (17th ed.) Citation

S, Koole, et al. "Primary Cytoreductive Surgery with or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for FIGO Stage III Epithelial Ovarian Cancer: OVHIPEC-2, a Phase III Randomized Clinical Trial." International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society 30, no. 6 (2020): 888. https://doi.org/10.1136/ijgc-2020-001231.

MLA (9th ed.) Citation

S, Koole, et al. "Primary Cytoreductive Surgery with or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for FIGO Stage III Epithelial Ovarian Cancer: OVHIPEC-2, a Phase III Randomized Clinical Trial." International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, vol. 30, no. 6, 2020, p. 888, https://doi.org/10.1136/ijgc-2020-001231.